litlas
Log inCreate account

Steven P. Balk

Active 1981–2025

Also published as
Steven P Balk
144
Papers
27,076
Citations
91
h-index
142
i10-index

Citations

Citations per year for Steven P. Balk1981: 4 citations1982: 6 citations1983: 5 citations1984: 5 citations1985: 2 citations1986: 1 citations1987: 1 citations1988: 2 citations1989: 2 citations1990: 14 citations1991: 22 citations1992: 17 citations1993: 24 citations1994: 45 citations1995: 74 citations1996: 50 citations1997: 63 citations1998: 133 citations1999: 181 citations2000: 191 citations2001: 204 citations2002: 234 citations2003: 258 citations2004: 289 citations2005: 228 citations2006: 167 citations2007: 187 citations2008: 193 citations2009: 188 citations2010: 187 citations2011: 221 citations2012: 236 citations2013: 342 citations2014: 276 citations2015: 251 citations2016: 246 citations2017: 228 citations2018: 233 citations2019: 712 citations2020: 686 citations2021: 797 citations2022: 647 citations2023: 519 citations2024: 663 citations2025: 309 citations2026: 9 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,432 citing papers, 35.3% of this breakdownChina: 1,156 citing papers, 11.9% of this breakdownUnited Kingdom: 676 citing papers, 6.9% of this breakdownCanada: 434 citing papers, 4.5% of this breakdownGermany: 369 citing papers, 3.8% of this breakdownJapan: 362 citing papers, 3.7% of this breakdownAustralia: 337 citing papers, 3.5% of this breakdownItaly: 301 citing papers, 3.1% of this breakdownFrance: 269 citing papers, 2.8% of this breakdownNetherlands: 204 citing papers, 2.1% of this breakdownSpain: 150 citing papers, 1.5% of this breakdownSwitzerland: 146 citing papers, 1.5% of this breakdown
0%35.3%Other 19.4%

Institutions

Fields

  • Medicine43.5%
  • Biochemistry, Genetics and Molecular Biology33.1%
  • Immunology and Microbiology20.6%
  • Neuroscience0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.3%
  • Agricultural and Biological Sciences0.3%
  • Other1.5%

Topics

  • Prostate Cancer Treatment and Research10.9%
  • Immune Cell Function and Interaction6.7%
  • T-cell and B-cell Immunology4.5%
  • Epigenetics and DNA Methylation2.9%
  • Prostate Cancer Diagnosis and Treatment2.7%
  • Estrogen and related hormone effects2.5%
  • Other69.8%

Coauthors

All papers

Open in search
  1. Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer

    Authors: Zeda Zhang, Wouter R. Karthaus, Young Sun Lee, Vianne R. Gao, Chao Wu, Joshua W. Russo, Menghan Liu, José Maurício Mota, Wassim Abida, Eliot Linton, Eugine Lee, Spencer Barnes, Hsuan-An Chen, Ninghui Mao, John Wongvipat, Danielle Choi, Xiaoping Chen, HuiYong Zhao, Katia Manova‐Todorova, Elisa de Stanchina, Mary-Ellen Taplin, Steven P. Balk, Dana E. Rathkopf, Anuradha Gopalan, Brett S. Carver, Ping Mu, Xuejun Jiang, Philip A. Watson, Charles L. Sawyers - Cancer Cell 2020 cited by 254

  2. EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

    Authors: Katherine L. Morel, Anjali V. Sheahan, Deborah L. Burkhart, Sylvan C. Baca, Nadia Boufaied, Yin Liu, Xintao Qiu, Israel Cañadas, Kevin Roehle, Max Heckler, Carla Calagua, Huihui Ye, Constantia Pantelidou, Phillip M. Galbo, Sukanya Panja, Antonina Mitrofanova, Scott Wilkinson, Nichelle C. Whitlock, Shana Y. Trostel, Anis Hamid, Adam S. Kibel, David A. Barbie, Atish D. Choudhury, Mark M. Pomerantz, Christopher J. Sweeney, Henry W. Long, David J. Einstein, Geoffrey I. Shapiro, Stephanie K. Dougan, Adam G. Sowalsky, Housheng Hansen He, Matthew L. Freedman, Steven P. Balk, Massimo Loda, David P. Labbé, Brian M. Olson, Leigh Ellis - Nature Cancer 2021 cited by 241

  3. EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

    Authors: Kexin Xu, Zhenhua J. Wu, Anna C. Groner, Housheng Hansen He, Changmeng Cai, Rosina T. Lis, Xiaoqiu Wu, Edward C. Stack, Massimo Loda, Tao Liu, Han Xu, Laura Cato, James E. Thornton, Richard I. Gregory, Colm Morrissey, Robert L. Vessella, Rodolfo Montironi, Cristina Magi‐Galluzzi, Philip W. Kantoff, Steven P. Balk, X. Shirley Liu, Myles Brown - Science 2012 cited by 887

  4. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer

    Authors: Adam Sharp, Ilsa M. Coleman, Wei Yuan, Cynthia C.T. Sprenger, David Dolling, Daniel Nava Rodrigues, Joshua W. Russo, Ines Figueiredo, Cláudia Bertan, George Seed, Ruth Riisnaes, Takuma Uo, Antje Neeb, Jonathan Welti, Colm Morrissey, Suzanne Carreira, Jun Luo, Peter S. Nelson, Steven P. Balk, Lawrence D. True, Johann S. de Bono, Stephen R. Plymate - Journal of Clinical Investigation 2018 cited by 393

  5. Transcriptional mediators of treatment resistance in lethal prostate cancer

    Authors: Meng Xiao He, Michael S. Cuoco, Jett Crowdis, Alice Bosma-Moody, Zhenwei Zhang, Kevin Bi, Abhay Kanodia, Mei-Ju Su, Sheng‐Yu Ku, Maria Mica Garcia, Amalia Sweet, Christopher Rodman, Laura DelloStritto, Rebecca Silver, John A. Steinharter, Parin Shah, Benjamin Izar, Nathan C. Walk, Kelly P. Burke, Ziad Bakouny, Alok K. Tewari, David Liu, Sabrina Y. Camp, Natalie I. Vokes, Keyan Salari, Jihye Park, Sébastien Vigneau, Lawrence Fong, Joshua W. Russo, Xin Yuan, Steven P. Balk, Himisha Beltran, Orit Rozenblatt–Rosen, Aviv Regev, Asaf Rotem, Mary‐Ellen Taplin, Eliezer M. Van Allen - Nature Medicine 2021 cited by 193

  6. LSD1 Inhibition Disrupts Super-Enhancer–Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer

    Authors: Muqing Li, Mingyu Liu, Wanting Han, Zifeng Wang, Dong Han, Susan Patalano, Jill A. Macoska, Steven P. Balk, Housheng Hansen He, Eva Corey, Shuai Gao, Changmeng Cai - Cancer Research 2023 cited by 68

  7. Biology of Prostate-Specific Antigen

    Authors: Steven P. Balk, Yoo-Joung Ko, Glenn J. Bubley - Journal of Clinical Oncology 2003 cited by 714

  8. ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer

    Authors: Shahrzad Rafiei, Kenyon Fitzpatrick, David Liu, Mu-Yan Cai, Haitham Elmarakeby, Jihye Park, Cora A. Ricker, Bose Kochupurakkal, Atish D. Choudhury, William C. Hahn, Steven P. Balk, Justin H. Hwang, Eliezer M. Van Allen, Kent W. Mouw - Cancer Research 2020 cited by 117

  9. Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer

    Authors: Shuai Gao, Sujun Chen, Dong Han, Zifeng Wang, Muqing Li, Wanting Han, Anna Besschetnova, Mingyu Liu, Feng Zhou, David A. Barrett, My Phu Luong, Jude Owiredu, Yi Liang, Musaddeque Ahmed, Jessica Petricca, Susan Patalano, Jill A. Macoska, Eva Corey, Sen Chen, Steven P. Balk, Housheng Hansen He, Changmeng Cai - Nature Genetics 2020 cited by 124

  10. Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer

    Authors: Qianben Wang, Wei Li, Yong Zhang, Xin Yuan, Kexin Xu, Jindan Yu, Zhong Chen, Rameen Beroukhim, Hongyun Wang, Mathieu Lupien, Tao Wu, Meredith M. Regan, Clifford A. Meyer, Jason S. Carroll, Arjun K. Manrai, Olli A. Jänne, Steven P. Balk, Rohit Mehra, Bo Han, Arul M. Chinnaiyan, Mark A. Rubin, Lawrence D. True, Michelangelo Fiorentino, Christopher Fiore, Massimo Loda, Philip W. Kantoff, X. Shirley Liu, Myles Brown - Cell 2009 cited by 911

  11. Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

    Authors: Lydia Lynch, Michael Nowak, Bindu Varghese, Justice Clark, Andrew E. Hogan, Vasillis Toxavidis, Steven P. Balk, Donal O’Shea, Cliona O’Farrelly, Mark A. Exley - Immunity 2012 cited by 496

  12. Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1

    Authors: Changmeng Cai, Housheng Hansen He, Sen Chen, Ilsa M. Coleman, Hongyun Wang, Zi Fang, Shaoyong Chen, Peter S. Nelson, Xia Liu, Myles Brown, Steven P. Balk - Cancer Cell 2011 cited by 459

  13. Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis

    Authors: Xin Yuan, Changmeng Cai, S Chen, S Chen, Zhentao Yu, Steven P. Balk - Oncogene 2013 cited by 385

  14. ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer

    Authors: Laura Cato, Jonas de Tribolet-Hardy, Irene Lee, Jaice T. Rottenberg, Ilsa M. Coleman, Diana Melchers, René Houtman, Tengfei Xiao, Wěi Li, Takuma Uo, Shihua Sun, Nane C Kuznik, Bettina Göppert, Fatma Özgün, Martin E. van Royen, Adriaan B. Houtsmuller, Raga Vadhi, Prakash K. Rao, Lewyn Li, Steven P. Balk, Robert B. Den, Bruce J. Trock, R. Jeffrey Karnes, Robert B. Jenkins, Eric A. Klein, Elai Davicioni, Friederike J. Gruhl, Henry W. Long, X. Shirley Liu, Andrew C.B. Cato, Nathan A. Lack, Peter S. Nelson, Stephen R. Plymate, Anna C. Groner, Myles Brown - Cancer Cell 2019 cited by 169

  15. Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity

    Authors: Akash Patnaik, Kenneth D. Swanson, Eva Csizmadia, Aniruddh Solanki, Natalie Landon‐Brace, Marina P. Gehring, Katja Helenius, Brian M. Olson, Athalia R. Pyzer, Lily C. Wang, Olivier Elemento, Jesse Novak, Thomas B. Thornley, John M. Asara, Laleh Montaser, Joshua J. Timmons, Todd M. Morgan, Yugang Wang, Elena Levantini, John G. Clohessy, Kathleen Kelly, Pier Paolo Pandolfi, Jacalyn Rosenblatt, David Avigan, Huihui Ye, Jeffrey M. Karp, Sabina Signoretti, Steven P. Balk, Lewis C. Cantley - Cancer Discovery 2017 cited by 148

  16. Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

    Authors: Mark A. Exley, Phillip Friedlander, Nadia Alatrakchi, Lianne Vriend, Simon Yue, Tetsuro Sasada, Wanyong Zeng, Yo Mizukami, Justice Clark, David M. Nemer, Kenneth LeClair, Christine Canning, Heather Daley, Glenn Dranoff, Anita Giobbie‐Hurder, F. Stephen Hodi, Jerome Ritz, Steven P. Balk - Clinical Cancer Research 2017 cited by 168

  17. Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer

    Authors: Michael Stanbrough, Glenn J. Bubley, Kenneth N. Ross, Todd R. Golub, Mark A. Rubin, T.M. Penning, Phillip G. Febbo, Steven P. Balk - Cancer Research 2006 cited by 1,076

  18. Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain.

    Authors: Steven A. Porcelli, C E Yockey, Michael B. Brenner, Steven P. Balk - The Journal of Experimental Medicine 1993 cited by 754

  19. Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer

    Authors: Mary‐Ellen Taplin, Glenn J. Bubley, Todd D. Shuster, Martha E. Frantz, Amy E. Spooner, George K. Ogata, Harold Keer, Steven P. Balk - New England Journal of Medicine 1995 cited by 1,253

  20. Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors

    Authors: André Richters, Shelby K. Doyle, David B. Freeman, Christina Lee, Becky Leifer, Sajjeev Jagannathan, Florian Kabinger, Jošt Vrabič Koren, Nicholas B. Struntz, Julie Urgiles, Ryan A. Stagg, Brice H. Curtin, Deep Chatterjee, Sebastian Mathea, Peter Mikochik, Tamara D. Hopkins, Hua Gao, Jonathan R. Branch, Hong Xin, Lori Westover, Gilles Bignan, Brent Rupnow, Kristen L. Karlin, Calla M. Olson, Thomas F. Westbrook, Joseph P. Vacca, Chris M. Wilfong, B. Wesley Trotter, Douglas C. Saffran, Norbert Bischofberger, Stefan Knapp, Joshua W. Russo, Ian Hickson, James R. Bischoff, Marco M. Gottardis, Steven P. Balk, Charles Y. Lin, Marius S. Pop, Angela N. Koehler - Cell chemical biology 2020 cited by 81

  21. Androgen receptor and MYC equilibration centralizes on developmental super-enhancer

    Authors: Haiyang Guo, Yiming Wu, Mannan Nouri, Sándor Spisák, Joshua W. Russo, Adam G. Sowalsky, Mark M. Pomerantz, Wei Zhao, Keegan Korthauer, Ji-Heui Seo, Liyang Wang, Seiji Arai, Matthew L. Freedman, Housheng Hansen He, Shaoyong Chen, Steven P. Balk - Nature Communications 2021 cited by 79

  22. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation

    Authors: Chen-Lin Hsieh, Fei Teng, Yiwen Chen, Tiantian Li, Yanfei Gao, Xiaodong Wang, Tong Sun, Christopher J. Sweeney, Gwo‐Shu Mary Lee, Shaoyong Chen, Steven P. Balk, Xiaole Shirley Liu, Myles Brown, Philip W. Kantoff - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 403

  23. Inhibition of EZH2 transactivation function sensitizes solid tumors to genotoxic stress

    Authors: Yiji Liao, Chen-Hao Chen, Tengfei Xiao, Bárbara de la Peña Avalos, Eloïse Dray, Changmeng Cai, Shuai Gao, Neel Shah, Zhao Zhang, Avery Feit, Pengya Xue, Zhijie Liu, Mei Yang, Ji Hoon Lee, Han Xu, Wei Li, Shenglin Mei, Roodolph St. Pierre, Shaokun Shu, Fei Teng, Melissa Duarte, Jin Zhao, James E. Bradner, Kornélia Polyák, Philip W. Kantoff, Henry W. Long, Steven P. Balk, X. Shirley Liu, Myles Brown, Kexin Xu - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 53

  24. ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer

    Authors: Changmeng Cai, Hongyun Wang, Housheng Hansen He, Sen Chen, Lingfeng He, Fen Ma, Lorelei A. Mucci, Qianben Wang, Christopher Fiore, Adam G. Sowalsky, Massimo Loda, Xia Liu, Myles Brown, Steven P. Balk, Xin Yuan - Journal of Clinical Investigation 2013 cited by 294